Sweet non-menthol, nicotine 36mg/ml for Nicotine Addiction

"Per information available on clinicaltrials.gov, this study is not currently recruiting patients; the trial was initially posted November 1st 2022 and last revised October 19th 2022. Despite its inactivity presently, there are a total of 181 other medical trials accepting applicants right now."

"This research requires a total of 40 volunteers between the ages 16-20 who have nicotine use disorder. Additionally, participants must be literate and within their lifetime, experimental e-cigarette usage should not exceed 10 times with no recent (past month) utilization."

"At present, this clinical trial is closed to new participants. The research initiative was posted on November 1st 2022 and the details were last updated on October 19th 2022. On the other hand, there are presently 110 trials accepting candidates with nicotine use disorder and 71 studies that study Nicotine 3 mg & Tobacco menthol admitting patients."

"Based on the current level of clinical research, our experts at Power judiciously rated Nicotine 3 mg, Tobacco menthol's safety a 1. This is due to this medication being in its first phase trial and having limited data pertaining to both efficacy and security."

"At the moment, there are 71 clinical trials for Nicotine 3 mg, Tobacco menthol in process with 5 of them being stage 3. Most of these experiments take place at locations situated around Green Bay, Wisconsin - but that number totals to 204 distinct sites worldwide."

"To be eligible for this trial, patients must fall between the ages of 16 to 20. Conversely, 8 studies are available for those younger than 18 while 131 trials exist specifically catered towards individuals over the age of 65."